32
Participants
Start Date
December 7, 2021
Primary Completion Date
August 1, 2022
Study Completion Date
August 1, 2022
Placebo
Placebo of saline solution of equal volume and infusion. Content of the infusion bag and tubing will be concealed with opaque covering.
Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS)
INOSARS is a polyvalent passive immunization based on anti-SARS-CoV-2 immunoglobulin F(ab')2 fragments from hyperimmune equine serum. Inactive ingredients: water for injection, sodium chloride and less than 10% of total protein content.
Hospital San José, Tec de Monterrey, Monterrey
Collaborators (1)
Inosan Biopharma
INDUSTRY
TecSalud Investigación Clínica
OTHER